Cargando…
CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity
Liver diseases are one of the leading causes of mortality in the world, mainly caused by different etiological agents, alcohol consumption, viruses, drug intoxication, and malnutrition. The maturation of gene therapy has heralded new avenues for developing effective interventions for these diseases....
Autores principales: | Xu, Tao, Li, Li, Liu, Yu-chen, Cao, Wei, Chen, Jia-si, Hu, Shuang, Liu, Ying, Li, Liang-yun, Zhou, Hong, Meng, Xiao-ming, Huang, Cheng, Zhang, Lei, Li, Jun, Zhou, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378651/ https://www.ncbi.nlm.nih.gov/pubmed/32760197 http://dx.doi.org/10.7150/ijbs.33481 |
Ejemplares similares
-
CRISPR/Cas9 Technology and Its Utility for Crop Improvement
por: Liu, Hua, et al.
Publicado: (2022) -
CRISPR/Cas9 technology: applications in oocytes and early embryos
por: Zhang, Yi-ran, et al.
Publicado: (2023) -
Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015) -
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
por: You, Liting, et al.
Publicado: (2019) -
The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems
por: Wang, Luyao, et al.
Publicado: (2022)